Vidrala SA (0NV7)
London Exchange · UK · prices in EUR · close of 20 Oct 2026
Key indicators
| Last close | EUR 90.30 |
|---|---|
| 52-week range | 70.50 – 91.80 |
| Return, 1 month / 3 months | +0.9% / +0.7% |
| Return, 1 year / 3 years | +11.6% / +38.5% |
| Trend | Uptrend |
| RSI (14) | 59 |
| Volatility (1 year) | 20.4% |
| Worst drawdown (1 year) | -21.3% |
| Average daily value traded | 0.13M EUR |
| Dividend yield | 1.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Vidrala is a Spanish manufacturer of glass containers based in the Basque Country. The company makes glass bottles and jars for customers in the beverage, food and other consumer goods industries, supplying packaging for drinks such as wine, beer and soft drinks as well as for food products. It runs glass production plants in Spain and other European countries, serving brand owners and packagers who need container glass for their products.
The shares are listed on the London Exchange in UK under the code 0NV7, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Vidrala SA (0NV7) trades on the London Exchange in UK. It last closed at EUR 90.30 on 20 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 985 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 11.6% and over the last three months it rose 0.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 77 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 8.0% | ||
| From 52-week high | -0.7% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 0.7% | ||
| 6-month return | 13.1% | ||
| 12-month return, skipping the last month | 10.6% | ||
| Stability (higher is calmer) | 78 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 20.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.3% | ||
| Liquidity | 33 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.13M EUR | ||
| Zero-volume days | 8.3% | ||
| Income | 47 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.5% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.9% |
|---|---|
| 1 month | +0.9% |
| 3 months | +0.7% |
| 6 months | +13.1% |
| 1 year | +11.6% |
| 3 years | +38.5% |
| 5 years | – |
Signals
| 50-day / 200-day average | 88.47 / 83.63 |
|---|---|
| Golden / death cross (60 days) | Golden, 59 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.39 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Jul 2026 | EUR 0.3797 |
| 11 Feb 2026 | EUR 0.9978 |
| 11 Jul 2025 | EUR 0.3452 |
| 12 Feb 2025 | EUR 0.9070 |
| 11 Jul 2024 | EUR 0.3138 |
| 10 Jul 2024 | EUR 3.2400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.